J-STAGE (Japan)
open access
Challenges in Regulating Synthetic New Psychoactive Substances: Lessons from Japan's Generic Scheduling against Hexahydrocannabihexol
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- 21 U.S.C. § 1705 — Development, submission, implementation, and assessment of National Drug Control Strategy#576905
- A randomized crossover trial comparing the acute physiological and psychological effects of botanical formulations of oral psilocybin, oral psilocin, and sublingual psilocin.#1079042
- Alternate-Day Buprenorphine Administration. Phase II - 4#839120
- Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence#982732
- Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility#841073
Record · ID 22751
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive